FDA takes step to protect consumers against dietary supplements containing dangerously high levels of extremely concentrated or pure caffeine

FDA Press Announcements Apr 16, 2018

Today, the US Food and Drug Administration took an important step to better protect consumers from the dangers of highly concentrated and pure caffeine products. These products present a significant public health threat because of the high risk that they will be erroneously used at excessive, potentially dangerous doses. Highly concentrated and pure caffeine, often sold in bulk packages, have been linked to at least two deaths in otherwise healthy individuals.

The agency issued a new guidance...

Go to Original

Family Medicine General Medicine

Non loggedin lock

To read this article Sign up / Login for free